Verastem VSTM
NASDAQ VSTM
$7.70 -0.20 (-2.53%)
At close: Oct 2, 2026 · 4:00 PM EDT

Verastem (VSTM) Return on Capital Employed [ROCE] (2012 - 2026)

Updated

Verastem (VSTM) recorded Return on Capital Employed [ROCE] of -114.94% in Q2 2026, up 22.85 percentage points from -137.79% a year earlier but down 14.60 percentage points from the prior quarter.

Analysis

Verastem (VSTM) Return on Capital Employed [ROCE] (2012 - 2026) Analysis & Trends

For FY2025, Verastem reported Return on Capital Employed [ROCE] of -167.25%, down 45.80 percentage points from FY2024.

  • Annual Return on Capital Employed [ROCE] has declined for five straight years, with a five-year change of -130.03 percentage points (FY2020 to FY2025).
  • Across earlier years, Return on Capital Employed [ROCE] came in at -121.45% in FY2024 (-25.53 pp), -95.92% in FY2023 (-4.97 pp), -90.95% in FY2022 (-36.57 pp) and -54.38% in FY2021 (-17.16 pp).
  • Quarterly Return on Capital Employed [ROCE] has ranged from -161.82% in Q1 2025 to -48.58% in Q3 2023 over the past five years.
  • On a year-over-year basis, Return on Capital Employed [ROCE] has increased for four consecutive quarters, with an average year-over-year change of -17.34 percentage points over the last eight quarters.
  • Peak year-over-year performance for Return on Capital Employed [ROCE] in the last five years was a gain of 61.48 percentage points in Q1 2026, against a drop of 96.94 percentage points in Q3 2024 at the low end.
  • Per Business Quant, the preceding three quarters came in at -100.34% (Q1 2026), -122.06% (Q4 2025) and -126.33% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 46.74%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 17.83%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 17.92%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 6.28%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 19.32%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 9.54%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 16.66%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -5.97%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 11.86%
10 Verastem 696.71 Mn 53.34 Mn 36.32 Mn -114.94%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -114.94%
Mar 31, 2026 -100.34%
Dec 31, 2025 -122.06%
Sep 30, 2025 -126.33%
Jun 30, 2025 -137.79%
Mar 31, 2025 -161.82%
Dec 31, 2024 -138.53%
Sep 30, 2024 -145.52%
Jun 30, 2024 -117.19%
Mar 31, 2024 -91.72%
Dec 31, 2023 -67.43%
Sep 30, 2023 -48.58%
Jun 30, 2023 -54.74%
Mar 31, 2023 -87.96%
Dec 31, 2022 -89.59%
Sep 30, 2022 -86.56%
Jun 30, 2022 -79.08%
Mar 31, 2022 -67.30%
Dec 31, 2021 -66.98%
Sep 30, 2021 -59.08%
API Access

Verastem Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=VSTM&period=max&api_key=YOUR_API_KEY